三门峡狐臭的简单方法-【艺美龄皮肤科】,艺美龄皮肤科,三门峡附近的专科医院处腋臭,三门峡什么办法能治狐臭,三门峡市哪家医院专门治疗痤疮,三门峡轻度腋臭做手术,三门峡治疗痤疮到那家医院好,三门峡那个医院的痤疮治的好

The Geminid meteor shower peaks this week, so hope for clear skies that will let you see a beautiful show of green fireballs on Thursday and Friday. This will be the last -- and strongest -- meteor shower of the year, according to NASA.This phenomenon was first recorded in 1862 and causes a show each December.In the hours before sunrise Friday, the most meteors will be visible in the North American sky, peaking about 7:30 a.m. ET, predicts Sky & Telescope. To see when they will peak in your part of the world, check here.But the morning isn't your only chance. On Thursday and Friday, keep an eye on the sky a few hours after sunset -- just keep the moon at your back.Although the Geminid shower is known for its "shooting stars," the number of meteors visible depends on the time and how dark it is. There will be fewer of them earlier in the evening, but the shower should hit a maximum of about 100 per hour around 2 a.m., NASA said. For those in the suburbs, expect about 30 to 40 per hour. And if you're in a city like New York, San Francisco or Atlanta, you probably won't see anything.Early evening meteors may be longer, with dramatic streaks that last several seconds. Later on, the meteors will present quicker streaks or leave trails of smoke that appear to glow.The asteroid 3200 Phaethon is responsible for this meteor shower, which is unusual because comets usually create meteor showers with icy debris. Scientists have debated the very nature of what Phaethon is. The closely tracked near-Earth asteroid has been likened to comets, so it's been called a "rock comet."Phaethon was discovered in October 1983 and named after the Greek myth about the son of Helios, the sun god, because it closely approaches our sun.Phaethon orbits the sun closer than any other asteroid and takes 1.4 years to orbit it. The asteroid heats to about 1,300 degrees Fahrenheit on closest approach to the sun, which causes it to shed dusty debris.These particles cause the meteor shower when they plunge into Earth's atmosphere at 22 miles per second, vaporizing in the streaks we call "shooting stars."If you live in an urban area, you may want to drive to a place that isn't littered with city lights that will obstruct your view. If you're able to find an area unaffected by light pollution, meteors could be visible every couple of minutes from 10 p.m. until dawn.Find an open area with a wide view of the sky, and don't forget to bundle up. Make sure you have a chair or blanket so you can look straight up. And give your eyes about 20 to 30 minutes to adjust to the darkness -- without looking at your phone -- so meteors are easier to spot.While you're keeping an eye out for the meteor shower, you might see a small, foggy green patch in the sky, NASA said. That will be Comet 46P/Wirtanen, which is making its closest approach to Earth -- within 7 million miles -- for the next 20 years. And it will be visible to the naked eye. The comet is expected to come closest to Earth and peak Sunday. 3007
The English city of Manchester came together Tuesday to mark the first anniversary of the terror attack that killed 22 people attending an Ariana Grande concert.Families of the victims, the injured, emergency services and local and national leaders were joined by UK Prime Minister Theresa May and Prince William, the Duke of Cambridge, for a memorial service at Manchester Cathedral.Those inside the cathedral were joined by thousands more across the country in a minute's silence to remember those killed in the suicide bombing as they left the Manchester Arena.Prince William read from Corinthians during a service full of song and tribute to the victims and their families. 685

The confirmed number of coronavirus cases in the U.S. has reached 5 million, by far the highest in the world. That’s according to the tally kept by Johns Hopkins University. Health officials believe the actual number is perhaps 10 times higher, or closer to 50 million, given testing limitations and the fact that as many as 40% of all those who are infected have no symptoms.The bleak milestone was reached as new cases in the U.S. run at about 54,000 a day. While that’s down from a peak of well over 70,000 in the second half of July, cases are rising in nearly 20 states, and deaths are climbing in most. Many Americans have resisted wearing masks and social distancing. 682
The Food and Drug Administration released updated safety standards Tuesday for makers of COVID-19 vaccines despite efforts by the White House to block them, clearing the way for requirements that are widely expected to prevent the introduction of a vaccine before Election Day.In the new guidelines posted on its website, the FDA said vaccine makers should follow trial participants for at least two months to rule out any major side effects before seeking emergency approval. That standard had been a sticking point between the FDA and White House officials, who said it could unreasonably delay the availability of COVID-19 vaccines.President Donald Trump has repeatedly insisted a vaccine could be authorized before Nov. 3, even though top government scientists working on the effort have said that timeline is very unlikely. On Monday Trump said vaccines are coming “momentarily,” in a video recorded after he returned to the White House.Former FDA officials have warned that public perception that a vaccine was being rushed out for political reasons could derail efforts to vaccinate millions of Americans.A senior administration official confirmed Monday that the White House had blocked FDA’s plans to formally publish the safety guidelines based on the two-month data requirement, arguing there was “no clinical or medical reason” for it.But on Tuesday, the FDA posted the guidance on its website, making clear that regulators plan to impose the safety standards for any vaccine seeking an expedited path to market.FDA Commissioner Stephen Hahn said in a statement that he hoped the guidelines would help “the public understand our science-based decision-making process that assures vaccine quality, safety and efficacy.”The requirements are aimed at companies seeking rapid approval through the FDA’s emergency authorization pathway. That accelerated process, reserved for health emergencies, allows medical products onto the market based on a lower bar than traditional FDA approval. But FDA has made clear only vaccines that are shown to be safe and effective will be authorized for coronavirus.Former FDA acting commissioner Dr. Stephen Ostroff said the requirements seem reasonable given the agency is in largely “uncharted territory” in terms of considering emergency use of a vaccine. The agency has only previously cleared one vaccine through the method — a decades-old shot that was authorized to prevent anthrax poisoning in 2005.“There really is no margin for error here,” Ostroff said. “Even when you’re talking about limited use of a vaccine there has to be some level of assurance that there isn’t a risk here that would far outweigh the benefit.”Dr. Peter Marks, the head of FDA’s vaccine division, said Tuesday that the two-month follow-up requirement was chosen to be “something reasonably aggressive, but not too conservative — right in the middle.” He spoke at a symposium organized by Johns Hopkins University.Initial doses of vaccines for emergency use would likely be reserved for medical workers and people with health conditions that make them particularly vulnerable to coronavirus. Full FDA approval for the general population will require significantly more data and is not expected until mid-2021.The White House attempt to block the guidance followed a string of instances in which the Trump administration has undercut its own medical experts working to combat the pandemic. FDA’s Hahn has been attempting to shore up public confidence in the vaccine review process for weeks, vowing that career scientists, not politicians, will decide if the shots are safe and effective.Pfizer CEO Albert Bourla has stoked excitement by saying that he expects data on whether the company’s candidate works to be ready in late October. But a number of variables would still have to align for the company to submit, and the FDA to review and greenlight, a vaccine application before Nov. 3. Pfizer’s competitors Moderna, AstraZeneca and Johnson & Johnson are working on longer research timelines.Vaccine development typically takes years, but the U.S. government has invested billions in efforts to accelerate the process and help multiple drugmakers prepare multiple candidates. All the doses will be purchased by the federal government for use vaccinating the U.S. population.Beyond exposing the rift between the White House and FDA, the delay in releasing the guidelines may have had limited practical effect.FDA scientists have been discussing the guidelines publicly for weeks and have made clear that the recommendations have already been shared with each of the vaccine developers.Former FDA Commissioner Scott Gottlieb said Tuesday that drugmakers depend on the FDA’s science-based endorsement to vouch for the safety and effectiveness of their products.“I can’t imagine a circumstance where a sponsor would challenge or seek to undermine the FDA’s role here,” Gottlieb said at the COVID-19 symposium. “This is precisely the moment when we need an objective, neutral arbiter.”Last week, Gottlieb and six other former FDA commissioners blasted the Trump administration for “undermining the credibility” of the agency in a op-ed calling for the release of the then-stalled vaccine guidelines.“Scientists should make decisions based on data, unfettered by political pressure or the intrusions of ideology or vested interests,” the officials wrote.___AP Medical Writer Lauran Neergaard contributed to this report.___The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content. 5644
The family whose dog died on a United Airlines flight in March has reached a settlement with the carrier, the family attorney and the airline said Thursday.The 10-month-old French bulldog named Kokito was inside an overhead bin on Flight 1284 from Houston to New York after a flight attendant told the passenger to put it there.When the plane landed at LaGuardia Airport, the dog was dead.The financial details of the settlement are confidential as part of the agreement, according to Evan Oshan, the attorney representing the Catalina Robledo family.United spokesman Charles Hobart said the airline began a comprehensive review of its animal transport policy and is collaborating with American Humane?to improve its practices. That group works to ensure the safety of animals."We are deeply sorry for this tragic accident and have worked with the Robledo family to reach a resolution," Hobart said.As a result of the incident, New York state Sen. Marisol Alcantara, a Manhattan Democrat, crafted legislation entitled Kokito's Law -- a new pet passenger bill of rights.Alcantera is the prime sponsor of the legislation, a measure is now in the state Senate Consumer Protection Committee.Among the proposals in the legislation are banning the placement of pets in overhead storage compartments, 1316
来源:资阳报